Becton Dickinson and Co (BDX.N)
BDX.N on New York Stock Exchange
252.51USD
4:01pm EDT
252.51USD
4:01pm EDT
Change (% chg)
$1.67 (+0.67%)
$1.67 (+0.67%)
Prev Close
$250.84
$250.84
Open
$251.48
$251.48
Day's High
$252.74
$252.74
Day's Low
$251.23
$251.23
Volume
245,626
245,626
Avg. Vol
287,820
287,820
52-wk High
$265.87
$265.87
52-wk Low
$208.67
$208.67
About
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of... (more)
Overall
| Beta: | 1.04 |
| Market Cap(Mil.): | $45,076.07 |
| Shares Outstanding(Mil.): | 227.57 |
| Dividend: | 0.73 |
| Yield (%): | 1.47 |
Financials
| BDX.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 56.67 | 31.72 | 32.67 |
| EPS (TTM): | 3.50 | -- | -- |
| ROI: | 2.84 | 14.11 | 14.49 |
| ROE: | 7.36 | 16.67 | 15.79 |
Becton Dickinson unit settles U.S. probe over unapproved medical devices
Becton Dickinson subsidiary CareFusion has agreed to pay $3.3 million to resolve claims that it bought and sold medical devices that did not have approval by the Food and Drug Administration, the Justice Department said on Monday.
Estimates